GLPwatch
Trials (2036)
Page 33 of 34.
- Efficacy of Oral Semaglutide in Overweight or Obesity
- Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
- A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
- Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
- A Study of LY3457263 in Obese Participants
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
- Liraglutide in Newly Onset Type 1 Diabetes.
- GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
- A Phase I Study of LY3502970 in Healthy Participants
- Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
- A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
- Tirzepatide in Obesity-Driven Endometrial Cancer
- SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
- Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
- Antiproteinuric Effects of Liraglutide Treatment
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- Effects of GLP-1 on Chronic Heart Failure
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
- A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
- Preoperative Condition in Giant Obese Patients
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus
- Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
- Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
- LIPT - Liraglutide in Polycystic Ovary Syndrome
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Incretin and KATP Channels
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
- A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
- The Effect of Weekly Semaglutide Treatment on Energy Expenditure
- Anti-obesity Pharmacotherapy and Inflammation
- Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
- A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
- Exenatide and Weight Loss for Diabetes Prevention
- The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
- Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)